The @entity2590 ( @entity2590 ) are characterized by bilineage or trilineage @entity1141 . Although diagnostic criteria are well established for @entity4289 , a significant number of @entity1 have blood and bone marrow findings that make diagnosis and classification difficult. Flow cytometric immunophenotyping is an accurate and highly sensitive method for detection of quantitative and qualitative abnormalities in hematopoietic cells. Flow cytometry was used to study hematopoietic cell populations in the bone marrow of 45 @entity1 with straightforward @entity4289 . The results were compared with those obtained in a series of @entity1 with @entity2150 , healthy donors, and @entity1 with a history of nonmyeloid @entity5 in complete remission. The @entity854 associated with @entity4289 were defined, and the diagnostic utility of flow cytometry was compared, with morphologic and cytogenetic evaluations in 20 difficult cases. Although morphology and cytogenetics were adequate for diagnosis in most cases, flow cytometry could detect @entity854 in cases when combined morphology and cytogenetics were nondiagnostic. It is concluded that flow cytometric immunophenotyping may help establish the diagnosis of @entity4289 , especially when morphology and cytogenetics are indeterminate. (Blood. 2001;98:979-987)

Diagnostic utility of flow cytometric immunophenotyping in XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity4289 :: ('MESH:D054221', 'Disease') :: ['MDS'] @entity5 :: ('MESH:D009369', 'Disease') :: ['neoplasia'] @entity2150 :: ('MESH:D000741', 'Disease') :: ['aplastic anemia'] @entity2590 :: ('MESH:D009190', 'Disease') :: ['MDSs', 'myelodysplastic syndromes'] @entity854 :: ('MESH:D018376', 'Disease') :: ['immunophenotypic abnormalities'] @entity1141 :: ('MESH:C535662', 'Disease') :: ['dysplasia']
@entity2590 :: (MESH:D009190,Disease) :: ['myelodysplastic syndrome']
